UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000054579 |
|---|---|
| Receipt number | R000062366 |
| Scientific Title | Study of the effects of food ingredient intake on body fat. (SBD-2024-02-RHKLU) |
| Date of disclosure of the study information | 2024/06/10 |
| Last modified on | 2025/05/29 17:37:02 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study of the effects of food ingredient intake on body fat. (SBD-2024-02-RHKLU)
Acronym
Study of the effects of food ingredient intake on body fat.
Scientific Title
Study of the effects of food ingredient intake on body fat. (SBD-2024-02-RHKLU)
Scientific Title:Acronym
Study of the effects of food ingredient intake on body fat.
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the effect of visceral fat reduction by food ingredient intake.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Abdominal visceral fat area
Key secondary outcomes
Abdominal total fat area, Abdominal subcutaneous fat area, Body weight, BMI, Waist circumferences
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Daily intake of test food for 16 weeks.
Interventions/Control_2
Daily intake of control food for 16 weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 65 | years-old | > |
Gender
Male and Female
Key inclusion criteria
(1) Males and females who are -> 20 years old at the time of IC acquisition and <65 years old at the end of the study.
(2) Subject, 25 kg/m2 <- BMI < 30 kg/m2.
(3) Those who can visit to destination medical institution on the scheduled date.
(4) Those who have submitted written informed consent after fully understanding the purpose and content of this study.
Key exclusion criteria
(1) Those with systolic blood pressure less than 90 mmHg.
(2) Women who wish to become pregnant, are/might be pregnant or lactating during the study.
(3) Those who are participating in other study or planning to participate or participated within the past 4 weeks.
(4) Those who are:
a) heart, liver, or kidney disease (including complications of other diseases)
b) having a history of cardiovascular disease
c) diabetes
d) allergic to test foods
e) having a respiratory illness
(5) Those who are receiving any treatment at the time of screening.
(6) Those who continuously take medicines.
(7) Those who continuously ingest foods for specified health use, foods with functional claims, health foods, and foods that may affect body fat evaluation.
(8) Those who heavy use of alcohol or smoke.
(9) Those who have regular hard exercise.
(10) Others who are judged inappropriate for participant by the investigator.
Target sample size
80
Research contact person
Name of lead principal investigator
| 1st name | Takao |
| Middle name | |
| Last name | Tanaka |
Organization
Suntory Holdings Limited
Division name
Research Strategy Planning Department
Zip code
135-8631
Address
2-3-3 Daiba, Minato-ku, Tokyo, Japan
TEL
050-1734-0590
Takao_Tanaka@suntory.co.jp
Public contact
Name of contact person
| 1st name | Hideyuki |
| Middle name | |
| Last name | Sasaki |
Organization
Suntory Holdings Limited
Division name
Research Strategy Planning Department
Zip code
135-8631
Address
2-3-3 Daiba, Minato-ku, Tokyo, Japan
TEL
050-1734-0683
Homepage URL
Hideyuki_Sasaki@suntory.co.jp
Sponsor or person
Institute
Suntory Holdings Limited
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Corporation Jikokai Fukuzumi Internal Medicine Clinic Clinical Trial Review Committee
Address
5th floor of the Ito-Yokado Fukuzumi store, 1-2-5 Fukuzumi-2 jo, Toyohira-ku, Sapporo-shi, Hokkaido.
Tel
011-836-3531
shibata@jkkai.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
福原医院（北海道） / Fukuhara Clinic (Hokkaido)
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 06 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
80
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2024 | Year | 06 | Month | 04 | Day |
Date of IRB
| 2024 | Year | 06 | Month | 03 | Day |
Anticipated trial start date
| 2024 | Year | 06 | Month | 11 | Day |
Last follow-up date
| 2024 | Year | 11 | Month | 23 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2024 | Year | 06 | Month | 05 | Day |
Last modified on
| 2025 | Year | 05 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062366
